shutterstock

Growing criticism over stratospheric cost of spinal muscular atrophy-fighting drug Zolgensma ignores trade-off value

Christopher Gerry | 
Novartis recently won FDA approval for Zolgensma, a new medicine that can potentially cure infants suffering from the otherwise fatal ...
4-15-2019 drug pill pricing weigh endpts tile

Gene therapy could be revolutionary—if we can figure out how to pay for it

James Paton | 
Dozens of revolutionary gene therapies that mend faulty strands of DNA are on their way, bringing the power to eliminate ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists